COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
暂无分享,去创建一个
S. Ng | G. Kaplan | J. Lewis | W. Reinisch | M. Kappelman | J. Colombel | I. Modesto | M. Agrawal | R. Ungaro | E. Brenner | F. Steinwurz | Joyce Wing Yan Mak | Xian Zhang | M. Kissous-Hunt | S. Ng
[1] M. Kappelman,et al. Reply , 2021, Gastroenterology.
[2] E. Loftus,et al. Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases. , 2020, Gastroenterology.
[3] S. Bunyavanich,et al. Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2). , 2020, JAMA.
[4] S. Pääbo,et al. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals , 2020, bioRxiv.
[5] E. Price-Haywood,et al. Hospitalization and Mortality among Black Patients and White Patients with Covid-19 , 2020, The New England journal of medicine.
[6] S. Ng,et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry , 2020, Gastroenterology.
[7] Anna María Nápoles,et al. COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.
[8] Tony Kirby,et al. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities , 2020, The Lancet Respiratory Medicine.
[9] R. Trimble. COVID-19 Dashboard , 2020 .